Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.
作者信息
Kain Renate, Rees Andrew J
机构信息
Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria
Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
出版信息
J Am Soc Nephrol. 2015 Sep;26(9):2065-7. doi: 10.1681/ASN.2015020138. Epub 2015 Mar 11.
Abstract
摘要
相似文献
1
Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.
J Am Soc Nephrol. 2015 Sep;26(9):2065-7. doi: 10.1681/ASN.2015020138. Epub 2015 Mar 11.
2
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11.
3
Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Nephrol Dial Transplant. 2016 Apr;31(4):574-85. doi: 10.1093/ndt/gfv384. Epub 2015 Nov 17.
4
ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
BMC Nephrol. 2015 Jun 30;16:90. doi: 10.1186/s12882-015-0091-8.
5
Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
J Leukoc Biol. 2016 Dec;100(6):1443-1452. doi: 10.1189/jlb.5A0116-037R. Epub 2016 Jun 30.
6
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
Biomed Res Int. 2015;2015:402826. doi: 10.1155/2015/402826. Epub 2015 Nov 25.
7
ANCA-associated vasculitis and anti-GBM disease: the experience in China.
Nephrol Dial Transplant. 2010 Jul;25(7):2062-5. doi: 10.1093/ndt/gfq134. Epub 2010 Mar 12.
8
Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review.
Ren Fail. 2013;35(3):414-7. doi: 10.3109/0886022X.2012.760356. Epub 2013 Jan 24.
9
Recurrent ANCA-associated vasculitis after renal transplantation.
Transplantation. 2010 Dec 15;90(11):1239-40. doi: 10.1097/TP.0b013e3181f9256a.
10
Plasma exchange for severe ANCA-associated vasculitis?
Am J Kidney Dis. 2011 Apr;57(4):532-5. doi: 10.1053/j.ajkd.2011.01.005.
本文引用的文献
1
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11.
2
Differential dermal expression of CCL17 and CCL18 in tuberculoid and lepromatous leprosy.
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3263. doi: 10.1371/journal.pntd.0003263. eCollection 2014.
3
Current and emerging techniques for ANCA detection in vasculitis.
Nat Rev Rheumatol. 2014 Aug;10(8):494-501. doi: 10.1038/nrrheum.2014.78. Epub 2014 Jun 3.
4
The immune system and kidney disease: basic concepts and clinical implications.
Nat Rev Immunol. 2013 Oct;13(10):738-53. doi: 10.1038/nri3523. Epub 2013 Sep 16.
5
Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.
J Invest Dermatol. 2014 Mar;134(3):695-703. doi: 10.1038/jid.2013.375. Epub 2013 Sep 4.
6
Identification of human CCR8 as a CCL18 receptor.
J Exp Med. 2013 Sep 23;210(10):1889-98. doi: 10.1084/jem.20130240. Epub 2013 Sep 2.
7
CCL18 exhibits a regulatory role through inhibition of receptor and glycosaminoglycan binding.
PLoS One. 2013 Aug 12;8(8):e72321. doi: 10.1371/journal.pone.0072321. eCollection 2013.
8
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.
9
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans.
Front Immunol. 2013 Jul 15;4:193. doi: 10.3389/fimmu.2013.00193. eCollection 2013.
10
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis Rheum. 2013 Sep;65(9):2441-9. doi: 10.1002/art.38044.
Zotero 插件